<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184401</url>
  </required_header>
  <id_info>
    <org_study_id>H-1902-077-1011</org_study_id>
    <nct_id>NCT04184401</nct_id>
  </id_info>
  <brief_title>Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT</brief_title>
  <official_title>Effect of Albumin Administration Strategy for Ascites Replacement on Time to 1st Flatus After Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GC Pharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate difference in the rate of recovery of intestinal
      motility according to different ascites replacement strategy after living donor liver
      transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to 1st flatus</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>Interval between SICU admission and 1st flatus</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to 1st diet</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>Interval between SICU admission and 1st diet</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Living Donor Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Replacement with albumin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Check drain amount every 4 hour after SICU admission
Replacement of 70% of drainage from previous 4 hours over next 4 hours
30% of the drainage with 5% albumin
40% of drainage with Hartmann's solution
If, serum K + level&gt; 5mEq/L, replace with 0.9% saline instead of Hartmann solution
If, serum albumin level is below 2.6 g/dL, inject 100mL of 20% albumin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Replacement with Hartmann's solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Check drain amount every 4 hour after SICU admission
Replacement of 70% of drainage from previous 4 hours with Hartmann's solution over next 4 hours
If, serum K + level&gt; 5mEq/L, replace with 0.9% saline instead of Hartmann solution
If, serum albumin level is below 2.6 g/dL, inject 100mL of 20% albumin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ascites replacement with albumin and hartmann's solution</intervention_name>
    <description>Combined strategy for ascites replacement
30% of ascites: replacement with 5% albumin
40% of ascites: replacement with Hartmann's solution</description>
    <arm_group_label>Replacement with albumin</arm_group_label>
    <other_name>Experimental</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ascites replacement with hartmann's solution</intervention_name>
    <description>Hartmann's solution only strategy for ascites replacement
- 70% of ascites: replacement with Hartmann's solution</description>
    <arm_group_label>Replacement with Hartmann's solution</arm_group_label>
    <other_name>No intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (19 years or older)

          -  Elective living donor liver transplantation

        Exclusion Criteria:

          -  Previous abdominal surgery

          -  Renal failure requiring renal replacement therapy

          -  Contraindications for 5% albumin use

               1. Condition with potential risk caused by increased circulating plasma (heart
                  failure, renal failure combined with oliguria, pulmonary edema)

               2. Hemolytic anemia

          -  Contraindications for Hartmann solution

               1. Progressive lactic acidosis

               2. Hypervolemia

               3. Hypernatremia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ho Geol Ryu, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ho Geol Ryu, MD, PhD</last_name>
    <phone>+82-2-2072-2065</phone>
    <email>hogeol@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seung-Young Oh, MD, MS</last_name>
    <phone>+82-2-2072-.098</phone>
    <email>faun1226@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Ho Geol Ryu, MD, PhD</last_name>
      <phone>+82-2072-2065</phone>
      <email>hogeol@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Seung-Young Oh, MD, MS</last_name>
      <phone>+82-2072-3098</phone>
      <email>faun1226@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ho Geol Ryu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>December 1, 2019</last_update_submitted>
  <last_update_submitted_qc>December 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ho Geol Ryu</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Ascites</keyword>
  <keyword>Albumin</keyword>
  <keyword>Hartmann's solution</keyword>
  <keyword>Postoperative ilues</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascites</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

